- Visibility 84 Views
- Downloads 48 Downloads
- Permissions
- DOI 10.18231/j.ijpp.47530.1758803757
-
CrossMark
A Cross-Sectional study on the quality and safety of weak opioid prescriptions in community pharmacies in Kayes, Mali
- Author Details:
-
Mahamadou Ballo *
-
Karim Traore
-
Mahamadou Dit Fodié Diefaga
-
Moussa Lougue
-
Sékou Bah
Mahamadou Ballo *
Background: Pain is one of the most common symptoms encountered in clinical practice and accounts for approximately two-thirds of all medical consultations. Depending on its intensity, pain is managed with analgesics of appropriate potency.
Objective: This study aimed to analyze the prescription patterns of weak opioids in community pharmacies in the city of Kayes.
Materials and Methods: A descriptive cross-sectional study was conducted across 12 community pharmacies over a six-month period from July to December 2024.
Results: A total of 357 medical prescriptions containing weak opioids were included. The over-45 age group was the most frequent, with 105 prescriptions. The average number of drugs per prescription was 3.98. Illegible prescriptions accounted for 13.16% (n=47). With regard to the pharmacography of the drugs prescribed, the dosage was not mentioned on 76.19% (n=272) of the prescriptions. The duration of treatment were not indicated on 98.32% (n=357) of prescriptions. Tramadol was the most prescribed step 2 analgesic at 55.74% (n=199). However, 36.13% (n=129) of prescriptions contained at least one drug interaction, including 12 contraindicated associations. Moreover, 5.32% (n=19) and 2.52% (n=9) of prescriptions contained at least one high-dose drug and one drug not required.
Conclusion: Overall, the average number of medications per prescription was high, and a significant number of prescriptions were illegible. The most frequent and serious prescribing errors were the omission of treatment duration and the use of contraindicated drug combinations.
References
- Cohen M, Quintner J, Rysewyk SV. Reconsidering the International Association for the Study of Pain definition of pain. Pain reports. 2018;3(2):e634. doi: 10.1097/PR9.0000000000000634.
- Ballo M, Cissé A, Bah S. Dispensation of Analgesics Survey in Private Pharmacies in Commune II of Bamako. 2021; 3(6): 156–160. Available from: https://www.easpublisher.com/media/ features_articles/EASJPP_36_156-160.pdf. doi: 10.36349/ easjpp.2021.v03i06.002
- Vaccines WHOAP on ED and. How to investigate drug use in health facilities: selected drug use indicators. Published online
- Accessed June 27, 2025. Available from: https://iris.who.int/ handle/10665/60519
- Brennan F, Carr DB, Cousins M. The role of opioids in pain management. Anesth Analg. 2007;105(6):1865–6. doi: 10.1213/01. ane.0000295243.31253.e9.
- Lucyk S, Nelson LS. Opioids. Crit. Care Toxicol. 2017;1237-1249. doi: 10.1007/978-3-319-17900-1_137
- Etat des lieux de la consommation des antalgiques opioïdes et leurs usages problematiques. Available from: https://www.omedit-idf.fr/ wp-content/uploads/2020/01/Rapport_Antalgiques-Opioides_Fev- 2019_3.pdf_2019-03-06.pdf
- Kertesz SG, Gordon AJ. A crisis of opioids and the limits of prescription control: United States. Addiction. 2019;114(1):169–180. doi:10.1111/ add.14394
- Dodo R, Zohoun A, Baglo T, Mehou J, Anani L. Urgences drépanocytaires au Service des maladies du sang du Centre national hospitalier universitaire-Hubert Koutoukou Maga de Cotonou, Bénin. Pan African Medical Journal. 2018;30(1). Available from: https://www.ajol.info/index.php/pamj/article/view/209756
- Caré W, Pinel S, Dufayet L, Langrand J, Micallef J, Vodovar D. Trends in adverse drug reactions related to oral weak opioid analgesics in therapeutic use in adults: A 10-year French vigilances retrospective study. Fundam Clin Pharmacol. 2023;37(6):1205-1217. doi:10.1111/ fcp.12929
- INSTAT. Résultats du RGPH5. Institut National de la Statistique du Mali|INSTAT. Accessed June 30, 2025. Available from: https:// instat-mali.org/fr/actualites-et-evenements/resultats-du-rgph5
- Cinquieme recensement general de la population et de l’habitat (RGPH5). Accessed June 30, 2025. Available from: https://instat- mali.org/laravel-filemanager/files/shares/rgph/rapport-resultats- globaux-rgph5_rgph.pdf
- Région de Kayes. In: Wikipédia. ; 2025. Accessed June 30, 2025. Available from: https://fr.wikipedia.org/w/index.php?title=R%C3%A9gion_de_ Kayes&oldid=226735404 Ballo et al. / Indian Journal of Pharmacy and Pharmacology 2025;12(3):176–181 181
- Sangho A, Sangho F, Kaloga A. Évaluation de la prescription et de la dispensation des médicaments au Mali en 2021. PAMJ-One Health. 2022;9(26). Accessed June 27, 2025. Available from: https://www.one-health.panafrican-med-journal.com/content/ article/9/26/full/
- Bilal AI, Osman ED, Mulugeta A. Assessment of medicines use pattern using World Health Organization’s Prescribing, Patient Care and Health facility indicators in selected health facilities in eastern Ethiopia. BMC Health Serv Res. 2016;16:144. doi:10.1186/ s12913-016-1414-6
- Ofori-Adjei YA, Fiakpornoo M. The influence of physicians’ specialty on prescribing patterns at a general medicine out-patients clinic. Ghana Med J. 2019;53(3):204-209.
- Fallaize R, Dovey G, Woolf S. Prescription legibility: bigger might actually be better. Postgrad Med J. 2018;94(1117):617–20. doi:10.1136/postgradmedj-2018-136010
- Volpe CRG, Melo EMM de, Aguiar LB de, Pinho DLM, Stival MM. Risk factors for medication errors in the electronic and manual prescription. Rev Lat Am Enfermagem. 2016;24:e2742. doi: 10.1590/1518-8345.0642.2742
- Suclupe S, Martinez-Zapata MJ, Mancebo J, Font-Vaquer A, Castillo-Masa AM, Viñolas I, et al. Medication errors in prescription and administration in critically ill patients. J Adv Nurs. 2020;76(5):1192–1200. doi:10.1111/jan.14322.
- Eberhart J. Tramadol, le succès paradoxal d’un antalgique pas banal. Douleurs : Évaluation - Diagnostic - Traitement . 2023;24(1):23–32. doi:10.1016/j.douler.2022.11.003
- Xie J, Strauss VY, Martinez-Laguna D, Carbonell-Abella C, Diez- Perez A, Nogues X, et al. Association of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Clinical Outcomes. JAMA 2021;326(15):1504. doi: 10.1001/ jama.2021.15255
- Traebert M, Dumotier B. Antimalarial drugs: QT prolongation and cardiac arrhythmias. Expert Opin. Drug Saf. 2005;4(3):421–431. doi: 10.1517/14740338.4.3.421
- Ehrenpreis ED, Roginsky G, Alexoff A, Smith DG. Domperidone is Commonly Prescribed With QT-Interacting Drugs. J. Clin. Gastroenterol. 2017;51(1):56–62. doi: 10.1097/mcg.0000000000000543
- Wiśniowska B, Tylutki Z, Wyszogrodzka G, Polak S. Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials. BMC Pharmacol. Toxicol. 2016;17(1). doi: 10.1186/s40360-016-0053-1
- Bonnan D, Amouroux F, Aulois-Griot M. Le bilan partagé de médication: intérêt de la mise en place d’un nouveau service pharmaceutique dans la detection de problemes lies aux therapeutiques. Ann. Pharm. Fr. 2021;79(5):597-603. doi:
- 1016/j.pharma.2021.02.009 Cite this article: Ballo M, Traore K, Diefaga MDF, Lougue M, Bah S. A Cross-Sectional study on the quality and safety of weak opioid prescriptions in community pharmacies in Kayes, Mali. Indian J Pharma Pharmacol. 2025;12(3):176–181